Dutta D, Bhattacharya S K, Bhattacharya M K, Deb A, Deb M, Manna B, Moitra A, Mukhopadhyay A K, Nair G B
National Institute of Cholera and Enteric Diseases, Calcutta, India.
J Antimicrob Chemother. 1996 Mar;37(3):575-81. doi: 10.1093/jac/37.3.575.
An open randomised controlled clinical trial with 160 adults with acute watery diarrhoea and severe dehydration compared the efficacy of varying regimens of norfloxacin and doxycycline for the treatment of cholera caused by Vibrio cholerae 0139 Bengal. Data were analysed for the 111 patients who were faeces culture positive for V. cholerae 0139. In addition to rehydration therapy, 28 patients received 300 mg of doxycycline as a single dose on admission, 26 patients received norfloxacin 400 mg bd for three days, 28 patients received a single dose of 800 mg of norfloxacin and 29 patients received no antibiotic (control group). Patients in the three treatment groups and control group had comparable characteristics on admission. All three treatment groups had reduced stool output, duration of diarrhoea and fluid intake compared with the control group. Multidose norfloxacin treatment significantly reduced stool output, duration of diarrhoea and fluid requirement compared with the other regimens.
一项针对160名患有急性水样腹泻和严重脱水的成年人的开放性随机对照临床试验,比较了不同方案的诺氟沙星和强力霉素治疗由0139孟加拉霍乱弧菌引起的霍乱的疗效。对111名粪便培养0139霍乱弧菌呈阳性的患者的数据进行了分析。除补液治疗外,28名患者入院时接受300毫克强力霉素单剂量治疗,26名患者接受诺氟沙星400毫克每日两次,共三天,28名患者接受800毫克诺氟沙星单剂量治疗,29名患者不接受抗生素治疗(对照组)。三个治疗组和对照组的患者入院时特征相当。与对照组相比,所有三个治疗组的粪便排出量、腹泻持续时间和液体摄入量均有所减少。与其他方案相比,多剂量诺氟沙星治疗显著减少了粪便排出量、腹泻持续时间和液体需求量。